Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

GNMX vs. SHSSX: which is better?

Bottom line

GNMX vs SHSSX: the short answer

GNMX (Corgi Genomics & Precision Medicine ETF) and SHSSX (Blackrock Health Sciences Opportunities Portfolio) are both etfs.

Updated Nov 19, 2026

GNMX vs SHSSX side by side

GNMXSHSSX
TypeETFMutual fund
Fund familyCorgi Genomics & Precision MedicineBlackRock
CategoryHealth Care SectorHealth Care Sector
Expense ratio—0.86%
Annual cost per $10k—$86
10-yr cost on $10k (prospectus)—$1,061
Max front loadNone0%
12b-1 fee—0%
1-yr return—+16.3%
5-yr return (annualized)—+5.9%
10-yr return (annualized)—+9.8%
Best quarter——
Worst quarter——
Net assets (fund)—$5.9B
Number of holdings—155
Portfolio turnover—49%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

GNMX and SHSSX share none of their top holdings.

GNMX top 10

    SHSSX top 10

    1. Eli Lilly & Company — 12.29%
    2. Johnson & Johnson — 8.77%
    3. Unitedhealth Group Inc — 6.10%
    4. Merck & Company Inc — 4.94%
    5. Gilead Sciences Inc — 4.19%
    6. Abbvie Inc — 3.94%
    7. Amgen Inc — 3.37%
    8. Thermo Fisher Scientific Inc — 3.02%
    9. Vertex Pharmaceuticals Inc — 2.74%
    10. Pfizer Inc — 2.61%

    FAQ

    What is the difference between GNMX and SHSSX?
    GNMX (Corgi Genomics & Precision Medicine ETF) and SHSSX (Blackrock Health Sciences Opportunities Portfolio) are both etfs.
    Should I own both GNMX and SHSSX?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.